How MFN clauses evolved in 2025 and what founders should accept or push back on in 2026 pre-seed rounds. Real examples inside.
Two years ago, a most-favored-nation clause in a SAFE note was straightforward: if you issued another SAFE on better terms before the first one converted, the earlier investor could elect to take those terms instead. It was a safety net for early believers. Clear mechanics, narrow scope, widely accepted.
That's not what's happening anymore.
In 2025, MFN clauses have mutated. Founders are now seeing MFN language that covers not just valuation caps but discount rates, pro-rata rights, board observation seats, information rights, and even future option pool adjustments. Some investors are stacking multiple MFN conditions into a single SAFE, creating a kind of "super MFN" that triggers across several dimensions simultaneously. Others are proposing time-based MFN clauses that only activate if you raise within a specific window, say 18 months, turning the clause into a hidden deadline that pressures founders to hit artificial milestones.
This matters because founders who accepted a standard MFN in 2023 are now discovering in 2026 that their cap tables are far more constrained than they thought. And new founders raising in 2026 are facing a negotiation landscape that's become genuinely confusing.
This guide walks through how MFN clauses actually work, why they've gotten weird, and what you should realistically accept versus push back on in pre-seed rounds.
Let's start with the fundamentals, because this is the part that gets garbled most often.
A most-favored-nation clause is an investor protection mechanism with a narrow, specific job: it protects an early SAFE holder against the company issuing another SAFE or convertible note on better terms before the first one converts.
Here's the basic logic:
You're an angel who writes a $50,000 check into your friend's startup via a SAFE with a $3 million post-money valuation cap. You believe in the team, but you're taking real risk. There's no guaranteed return, the company might fail, and you're investing at a stage when information is scarce.
Six months later, the market softens and the company needs a bridge to reach its seed round. It issues a new SAFE to a different investor at a $2 million cap. That investor is buying the same company cheaper than you did, with six more months of evidence that it works. You took the risk first, and the person who showed up later got the better price.
That is the situation MFN addresses. Without it, you sit at $3 million while the new investor sits at $2 million. With it, the company has to tell you about the new terms, and you can elect to amend your SAFE to match them.
Two details matter, and both are routinely misstated:
Lower is better. A lower valuation cap means you convert at a cheaper price and get more shares for the same money. If the new investor comes in at a $4 million cap, that is worse than your $3 million, and MFN does nothing, because there is nothing better to take. MFN only ever reaches down.
It applies to later SAFEs, not to the priced round. YC's standard SAFE documents tie the MFN provision to convertible securities the company issues before your SAFE converts. When the priced round finally arrives, your SAFE converts on whatever cap and discount it holds at that moment, and the MFN provision terminates. A priced round has a pre-money valuation and a share price. It does not have a "valuation cap" for your MFN to match against.
The investor's argument for MFN is sound: early risk shouldn't be quietly repriced by someone who wrote a check three months later. The founder's problem is friction. MFN turns every bridge SAFE into a repricing event for everyone who came before, and as the next section shows, the bill lands on the founders.
Let's work through an example with real numbers.
The setup:
What happens?
Investor B's $1.5 million cap is more favorable than Investor A's $2 million cap. That is the trigger. The company is obligated to notify Investor A of the new terms, and Investor A can elect to amend their SAFE down to the $1.5 million cap.
Run the numbers. On a post-money SAFE, the cap tells you directly what the money buys as a percentage of the company after all SAFEs convert but before new priced-round money arrives:
Investor A's election is worth about 3.3 points. Note where those points come from: not from Investor B, and not from the seed investor who hasn't shown up yet. They come out of the common stock, which means the founders and the option pool.
Now the part that gets written up wrong constantly.
Suppose instead that no bridge SAFE ever happens, and a year later you raise a $1 million seed round at a $5 million post-money valuation.
Nothing triggers. There is no other convertible security to compare against, and a priced round is not a SAFE. Investor A converts at their $2 million cap, the MFN provision terminates, and everyone moves on.
Investor A also has no reason to want anything else. Their $2 million cap is far better than the seed price. A $5 million post-money on a $1 million raise implies a $4 million pre-money, which against 10,000,000 pre-round shares is $0.40 per share. Investor A's $2 million cap prices them somewhere around $0.18 to $0.20 per share, depending on how the SAFE defines the capitalization. The cap is worth roughly twice the seed price to them. An investor "upgrading" from a $2 million cap to the seed round's terms, even with a 20 percent discount bolted on, would be volunteering to pay about double for the same shares.
This is worth stating plainly because an earlier version of this article got it backwards, and a reader wrote in to correct us. A higher valuation in your next round is not a better deal for your SAFE holder. It is a worse one, and the cap they already hold is what protects them from it. MFN has nothing to add.
SAFE Agreements for Startups (2026 Guide) provides more nuance on how these conversions play out across different SAFE structures, and it's worth reading if you're modeling cap table scenarios.
The standard MFN clause is clean. But in 2025, we're seeing several mutations:
Traditional MFN only covers valuation caps. New versions cover multiple terms simultaneously. An investor might negotiate an MFN that triggers on:
When you trigger one dimension, you might trigger all of them. This is a "super MFN" and it dramatically increases the friction in future rounds. A Series A investor might accept that your pre-seed investor gets a better valuation, but they won't accept that the pre-seed investor also gets a board seat and pro-rata rights without negotiating those separately.
Some investors are now proposing MFN clauses that only apply if the next financing event happens within a specific window, typically 18 to 24 months. The logic: if you're still fundraising 18 months later, you haven't progressed enough to deserve the MFN protection.
This is problematic because it creates a hidden deadline. A founder might not realize they're under time pressure until they're 16 months in and suddenly realize that if they don't close a seed round in the next two months, their pre-seed investors lose MFN protection. That pressure can lead to bad decisions.
Imagine this scenario: you raise $100,000 from Angel A with an MFN clause. Three months later, you raise $100,000 from Angel B with a separate MFN clause. Then you raise from Angel C, who negotiates hard and gets a materially lower cap. Because A and B both hold MFN, C's terms flow backward to both of them.
This creates a daisy chain where the best terms any single investor negotiates propagate to everyone who came earlier. It's not uncommon for founders to end up with 8 to 10 pre-seed investors, each with MFN clauses, all tied together. The cumulative effect is that your most aggressive negotiator effectively sets the price for the entire pre-seed round, and you won't feel it until the last SAFE is signed.
Traditionally, MFN applies to the economic terms of a convertible security: valuation cap, discount, and similar. But some investors are now trying to extend MFN to unpriced terms like option pool size, vesting schedules, or even founder equity percentages.
For example: "If you grant the next hire a 0.5% option grant, my MFN clause gives me the right to a 0.5% equity grant as well." This is unusual and generally founder-hostile, but it's appearing in term sheets.
Some investors are proposing MFN clauses that only trigger if certain conditions are met. For example:
These conditional clauses reduce the investor's protection but also reduce founder friction. They're becoming more common as a compromise.
Three factors explain why MFN clauses have become more complex in 2025:
Market Tightness: In 2023-2024, capital was scarce relative to deal flow. Founders had leverage. Investors had to accept simpler terms to get deals done. In 2025, the market has tightened further. There are more founders, more SAFE rounds, and more competition for capital. Investors are pushing harder on terms because they can.
Cap Table Complexity: As more founders are raising multiple pre-seed rounds (often called rolling pre-seeds), the cap table gets messier. Investors are using MFN clauses as a way to hedge against cap table surprises. Instead of negotiating each round individually, they're trying to build in protections that automatically adjust.
SAFE Commoditization: Most Favored Nation (MFN) SAFEs: What Startup Founders Need to Know notes that as SAFEs have become the standard pre-seed instrument, investors have become more creative about how they use MFN clauses to differentiate their deals. If everyone is using SAFEs, the MFN clause becomes a way to add value or protection.
Founder Education Gaps: Frankly, many founders don't fully understand MFN clauses. They accept them without negotiating because they seem standard. Investors have noticed this and have started pushing more aggressive versions.
Let's be practical. You're raising a pre-seed round in 2026. You're likely to encounter MFN clauses. Here's what's reasonable to accept:
This is the baseline. Accept it. It's not worth fighting over, and it signals good faith to your investors. A standard MFN clause that says "if you issue another SAFE at a lower cap before mine converts, I can take that cap" is fair. It protects early investors against being undercut by the next check, and it costs you nothing unless you actually go raise cheaper money.
Example language: "If the Company issues any Safe or convertible promissory note prior to the termination of this Safe with terms more favorable to the holder than those of this Safe, the Company shall promptly notify the Investor, and the Investor may elect to amend this Safe to reflect those terms."
Note what that language does and doesn't reach. It's triggered by the next convertible security, not by your eventual priced round, and it gives the investor an election rather than an automatic adjustment.
If an investor is accepting a valuation cap instead of a discount, they might ask for MFN protection on discount rate too, so that a later SAFE carrying a discount doesn't leave them behind. This is acceptable if it's capped. For example:
"If the Company issues a subsequent Safe carrying a discount, this Safe shall be amended to include that discount, up to a maximum of 20%."
This protects the investor without creating unlimited exposure. A 20% discount is standard, so this is a reasonable ask.
Pro-rata rights are valuable, and investors are increasingly asking for MFN protection on them. If you're granting pro-rata rights to some pre-seed investors, it's fair that others with MFN clauses also get them. But you can negotiate carve-outs:
Now here's where you need to draw lines:
Don't accept an MFN clause that covers board seats, information rights, liquidation preferences, and valuation caps all at once. These should be negotiated separately. If an investor wants a board seat, that's a separate negotiation from valuation cap protection.
What to say: "I'm comfortable with MFN on valuation cap. Board observation rights are something I negotiate separately based on investment size and investor fit. Let's handle those as distinct conversations."
Reject MFN clauses that expire after 18 or 24 months. This creates artificial pressure and hidden deadlines. If you're going to give MFN protection, it should apply until the company raises a priced round, not until some arbitrary date.
What to say: "I'll give you MFN protection through the next priced round, whenever that happens. I won't agree to a time-based expiration because it creates pressure to fundraise on an artificial timeline."
Absolutely push back on MFN clauses that extend to option pool size, vesting schedules, founder equity, or other non-valuation terms. These are operational decisions that shouldn't be locked in by investor MFN clauses.
What to say: "MFN applies to valuation and financing terms. It doesn't apply to operational decisions like option pool size or hiring grants. Those are founder decisions."
If you're raising from multiple pre-seed investors, each with an MFN clause, you need to understand that they're all tied together. This isn't necessarily a reason to reject the round, but you need to be aware of it.
What you should do: Create a cap table model where you map out the cumulative effect of all MFN clauses. What's the worst-case scenario if the seed round comes at a much lower valuation? How much dilution happens? Most Favored Nation (MFN) Clause provides frameworks for thinking through these scenarios.
Conditional MFN is actually reasonable, but you need to negotiate the conditions carefully. If an investor wants MFN to only apply to "qualified financings" (rounds over $500K), that's fine. But make sure the definition is clear and realistic for your business.
What to negotiate: The threshold for a "qualified financing." $500K might be too high for your market. Propose $250K or a minimum check size instead.
Let's model a realistic scenario, because the cost of MFN shows up somewhere founders don't expect.
Pre-seed (January 2026):
At a $2 million cap, each angel's $100,000 buys 5 percent. Together they hold 15 percent.
The bridge (November 2026):
The seed round is taking longer than planned. You raise another $200,000 from Angel D to extend runway, and because the market has moved against you, D prices it at a $1.2 million cap.
That's the trigger. D's cap is more favorable than the $2 million that A, B, and C hold, so all three get notified and all three elect to amend. Here is the before and after, measured as a share of the company once all SAFEs convert but before seed money arrives:
| Holder | Without MFN | With MFN |
|---|---|---|
| Angel A | 5.0% | 8.3% |
| Angel B | 5.0% | 8.3% |
| Angel C | 5.0% | 8.3% |
| Angel D | 16.7% | 16.7% |
| Founders and option pool | 68.3% | 58.3% |
The MFN election moved 10 points from the founders to the angels. Angel D is untouched. This is the part that surprises people: MFN doesn't reprice the new investor, and it doesn't reprice the future seed investor. It reprices you.
The seed round (2027):
A seed fund invests $2 million at a $10 million post-money valuation, taking 20 percent. Everyone already on the cap table is diluted proportionally:
| Holder | Without MFN | With MFN |
|---|---|---|
| Angels A, B, and C | 12.0% | 20.0% |
| Angel D | 13.3% | 13.3% |
| Founders and option pool | 54.7% | 46.7% |
| Seed fund | 20.0% | 20.0% |
You've given up 8 points of the post-seed company. Not because the seed round came in low, and not because of anything the seed fund negotiated, but because you took a $200,000 bridge at a cap below what your first three angels held.
That's the real lesson of MFN math, and it's a bigger number than most founders expect. The clause sits dormant right up until the moment you need money on worse terms than last time, which is exactly the moment you can least afford it. SAFEs - Dentons ventureBeyond goes deeper into these cap table dynamics if you want to model more complex scenarios.
Here's a practical negotiation framework:
Start by proposing the simplest possible MFN clause: valuation cap only, no time limit, standard 20% discount on priced rounds. Many investors will accept this because it's standard.
Sample language: "I'm happy to include a standard MFN clause on valuation cap. If we raise a priced round at a lower valuation cap, your cap adjusts automatically."
Before pushing back on MFN, ask the investor why they want it. Often it's not actually about valuation protection. It's about feeling like they're not getting screwed. If you can address the underlying concern differently, you might not need a complex MFN clause.
For example: "I'm concerned that if you raise a seed round, my early investment will look bad in hindsight."
You could respond: "I understand. I'm planning to raise a seed at a higher valuation than this pre-seed, not lower. But I'll give you MFN protection on valuation cap so you're protected if that changes."
If an investor is pushing for a complex MFN clause (multi-dimensional, time-gated, etc.), you can negotiate by offering something else they want.
For example: "I can give you pro-rata rights through the Series A instead of a multi-dimensional MFN clause. That gives you more concrete protection."
Once you've negotiated MFN terms, make sure they're crystal clear in the SAFE document. Ambiguous MFN clauses create disputes later. YC Combinator's SAFE documents provide standard language you can use as a baseline and modify.
Specifically, document:
Before you accept an MFN clause, model the worst-case scenario. What if your seed round comes at a much lower valuation than you expect? How much dilution happens? Is it acceptable?
If the answer is no, push back on the MFN clause or negotiate limits.
MFN clauses don't exist in isolation. They're part of your broader fundraising approach. As you think about pre-seed rounds in 2026, consider how MFN fits into your overall strategy.
If you're planning to raise multiple small pre-seed rounds from angels, MFN clauses become more complex. Each investor gets tied together through their MFN clauses, which can create friction in future rounds. You might be better off raising fewer, larger pre-seed checks to simplify your cap table.
Alternatively, you could negotiate different MFN terms with different investors. Some might get standard MFN on valuation, others might get conditional MFN (only if you issue a subsequent SAFE above a certain size), and still others might not get MFN at all in exchange for a lower valuation cap.
This is where reading 11 Capital Raising Playbooks for Startup Founders becomes valuable. It shows different approaches to structuring pre-seed rounds depending on your specific situation.
Also, as you're thinking about your pitch and positioning, remember that how you present your valuation affects how investors view MFN. If you're raising at a $2 million cap and you position it as a "pre-seed" round, investors might be more aggressive about MFN because they expect the seed to be significantly higher. If you position it as "early seed," they might be more reasonable.
Based on what we're seeing in 2025-2026, here are the most common errors:
Many founders sign SAFEs with MFN clauses without fully understanding what they're agreeing to. They assume it's standard and move on. Then, 18 months later, when they take a bridge on cheaper terms to reach the seed round, every earlier SAFE reprices at once and the dilution lands on the founders.
Don't do this. Take 30 minutes to understand exactly what the MFN clause says and model the cap table impact.
If you're raising from multiple pre-seed investors, each with an MFN clause, you need a master document that shows how they all interact. Without this, you'll face disputes later.
A time-gated MFN clause (that expires after 18 months) creates hidden pressure to fundraise on a timeline. Many founders don't realize this until they're 16 months in and suddenly feel rushed.
MFN clauses can be negotiated. Many founders accept them as written without pushing back. Even small changes, like capping pro-rata rights at a certain ownership percentage or defining "qualified financing" narrowly, can significantly reduce friction.
Some founders think MFN is the same as a valuation cap. It's not. A valuation cap is a fixed number. MFN is a protection that adjusts your terms if others get better terms. These are different things and should be negotiated separately.
Based on current trends, here's what we expect:
MFN clauses will become more standardized, but more complex. As more founders accept them, investors will push for more sophisticated versions. We'll see more multi-dimensional MFN, more conditional MFN, and more creative trigger mechanisms.
Founders will push back harder. As more founders understand the cap table impact of MFN clauses, they'll negotiate more aggressively. We'll see more founders rejecting MFN entirely or proposing alternatives like tiered pro-rata rights or information rights instead.
Lawyers will get more creative. The legal community will develop more nuanced MFN language that protects investors without creating excessive founder friction. We'll see more conditional MFN clauses, more time-limited MFN, and more MFN clauses that only apply to specific types of rounds.
Platforms will help. Tools like 15 AI-Powered Fundraising Tools Every Founder Should Know are starting to include cap table modeling and SAFE term analysis. Expect more of these tools to help founders understand MFN clauses before they sign.
Here's what you should do:
1. Understand MFN before you fundraise. Spend an hour learning how MFN clauses work. Read the standard definitions from Most Favored Nation Clause | SAFEs and Convertible Notes and model a few scenarios.
2. Accept standard MFN on valuation cap. This is table stakes. Don't waste negotiating capital here.
3. Push back on multi-dimensional MFN. Separate board seats, pro-rata rights, and information rights from valuation MFN. Negotiate them independently.
4. Reject time-based MFN. Don't accept MFN clauses that expire after a certain period. If you're giving MFN protection, it should apply until a priced round, not until an arbitrary date.
5. Model the cap table impact. Before you accept MFN from multiple investors, understand what your cap table looks like in various scenarios.
6. Document everything clearly. Once you've negotiated terms, make sure the SAFE language is crystal clear. Ambiguity creates disputes.
7. Consider alternatives. If investors are pushing for aggressive MFN clauses, propose alternatives like tiered pro-rata rights, information rights, or board observation seats instead.
MFN clauses are here to stay, and they're getting weirder. But they're also negotiable. The founders who understand them and negotiate confidently will have cleaner cap tables and fewer surprises down the road.
If you're in the middle of a pre-seed round and facing MFN negotiations, take the time to understand exactly what you're agreeing to. Your future self will thank you.
For more context on how to approach your pre-seed round strategically, check out 5 Steps to Create an Outstanding Capital Raising Plan [Free Templates] and 5 Proven Strategies to Raise Private Money for Your Startup to see how MFN fits into your broader fundraising approach. And if you're preparing for investor conversations, review 21 Pitch Mistakes Investors See Every Week to avoid common errors that might make investors more aggressive about MFN terms.
Also, if you're raising for an AI startup specifically, AI Startup Valuations: The Reality Check You Need for Fundraising Success covers how valuation expectations have shifted in 2025, which directly affects how MFN clauses play out. And All-In Podcast Insights: What David Sacks Really Advises Founders About Valuations in 2025 provides insider perspective on what experienced investors actually think about valuation and structure in this environment.
Finally, if you want to understand the broader fundraising landscape and common myths, 10 Fundraising Myths Founders Still Believe (And the Truth) covers misconceptions about SAFE notes, valuations, and investor expectations that often lead founders to accept bad MFN terms in the first place.
Capitaly is the AI native platform for capital raising: a shared investor inbox, CRM, deal room, and pipeline, with always on AI agents that help you run the whole raise from one place.